The global Gamma Linolenic Acid (GLA) market is projected to be valued at USD 197.2 million in 2025, with a forecasted compound annual growth rate (CAGR) of 4.9%, leading to an estimated value of USD 269.8 million by 2035. From 2020 to 2025, the market registered a CAGR of 4.3%. The increasing demand for GLA is driven by a growing consumer preference for healthier lifestyles and the rising awareness of its heart health benefits.
As an omega-6 polyunsaturated fatty acid, GLA is vital in maintaining cardiovascular health, which is contributing to its increasing consumption worldwide. People can either naturally integrate GLA into their diets or consume various food ingredients rich in this compound.
The therapeutic benefits of Gamma Linolenic Acid are significantly driving market growth. GLA, found in plant seed oils such as black currant, borage, and evening primrose, is essential for human health maintenance. Its demand is rising as it is widely used to treat conditions like eczema, diabetes, arthritis, high blood pressure, and more.
| Attribute | Value |
|---|---|
| Market Size in 2025 | USD 197.2 million |
| Market Size in 2035 | USD 269.8 million |
| CAGR (2025 to 2035) | 4.9% |
Although the efficacy of these applications is not always supported by solid scientific data, the therapeutic appeal of GLA continues to grow. In 2024, Changsha Vigorous-Tech Co., Ltd., a leading company from China, participated in major industry exhibitions such as SupplySide West and CPhI China, showcasing its botanical extracts and derivatives relevant to the GLA market. This highlights the growing interest and involvement in GLA as a key ingredient in the natural health and wellness industry.
The demand for GLA is also supported by its use in several industries, including food and beverages, pharmaceuticals, dietary supplements, and animal nutrition. Cherish Pharma (India) has been involved in the development of dietary supplements incorporating GLA, focusing on formulations that support skin health and hormonal balance.
In the pharmaceutical space, Acme (USA) is conducting research on the applications of GLA in anti-inflammatory treatments. Furthermore, Charkit Chemical (USA) supplies various fatty acids, including GLA, to the nutraceutical and cosmetic industries, supporting the growing demand for natural ingredients.
Cailà & Parés (Spain) manufactures polyunsaturated fatty acids, including linolenic acid, which are utilized in various industrial applications like the production of resins and detergents. These ongoing initiatives and product offerings contribute to the continued growth and diversification of the GLA market.
The Gamma Linolenic Acid (GLA) market is poised for growth, driven by key segments like liquid GLA and dietary supplements. Liquid GLA is anticipated to lead the form segment, while dietary supplements will remain a significant part of the end-use segment. These two segments are expected to play a key role in the market’s continued expansion, supported by consumer demand for natural, effective health solutions.
Liquid GLA is expected to dominate the Gamma Linolenic Acid market, capturing 69.1% of the market share by 2025. This form is favored for its versatility and ease of incorporation into various products, making it the preferred choice in industries like dietary supplements, pharmaceuticals, and cosmetics.
In dietary supplements, liquid GLA can be easily integrated into soft gels and capsules, making it convenient for consumers to incorporate into their daily wellness routines. In the cosmetics industry, liquid GLA is valued for its anti-inflammatory and moisturizing properties, making it a sought-after ingredient for skincare products such as lotions, serums, and creams.
The increasing preference for natural ingredients in personal care products has further propelled the demand for liquid GLA, with a rising focus on skincare solutions that prioritize plant-based, effective ingredients. As the trend toward natural wellness products continues to grow, liquid GLA is expected to maintain its dominant position in the market.
Dietary supplements are anticipated to capture 33.8% of the Gamma Linolenic Acid (GLA) market share by 2025. The increasing consumer shift towards health-conscious decisions and preventive healthcare is driving the growing demand for natural supplements, including those containing GLA.
These supplements are commonly marketed for their potential benefits such as supporting skin health, reducing inflammation, and balancing hormones, all of which align with the rising focus on holistic wellness. GLA is seen as an effective ingredient in addressing common health concerns, which has contributed to its growing popularity in the dietary supplement industry.
Leading companies such as Nature’s Way, Sundown Naturals, and Now Foods have been integrating GLA into their product offerings to cater to the demand for natural health solutions. The increasing incorporation of GLA in functional foods such as smoothies, dietary snacks, and energy bars is also boosting the market. As the demand for natural, preventive wellness products rises, the dietary supplements segment is expected to continue playing a major role in the growth of the GLA market, with consumers increasingly turning to natural solutions for better overall health.
Demand for Healthy Supplements Driving Market Growth
The increasing demand for gamma linolenic acid (GLA) in dietary supplements is being driven by consumer awareness of the health benefits linked to GLA. An omega-6 fatty acid called GLA which is present in plant-based oils like borage and evening primrose is becoming more well-known for its anti-inflammatory qualities.
Due to these advantages it is now used to treat inflammatory diseases like rheumatoid arthritis and eczema. GLA-enriched supplements are becoming more and more popular as consumers look for natural solutions which is helping to support their growing market share.
In the upcoming years the market for gamma linolenic acid is anticipated to grow due to consumers increasing preference for natural health products. As more people become aware of GLAs therapeutic benefits more people are including GLA supplements in their wellness regimens. Among people searching for alternatives to pharmaceutical treatments this trend is especially prominent. Since GLA satisfies the demands of consumers looking for natural solutions who are health-conscious the market is expected to continue growing.
Rise in Awareness in Arthritis Driving Market Growth
It is anticipated that the growing incidence of rheumatoid arthritis will increase demand for gamma linolenic acid which is contributing to the expansion of the global gamma linolenic acid market. A study released by the Arthritis Foundation in 2017 estimated that 54. 4% of Americans have arthritis according to a new study.
Joint pain and swelling are the most typical signs of arthritis. Gamma linolenic acid is a good choice in these situations because it reduces inflammation and helps avoid arthritis. Consumers around the world are becoming more health conscious and their lifestyles have changed significantly.
This element is thought to contribute to the market expansion for gamma linolenic acid. Consumers these days favor goods with natural nutrient-dense ingredients that provide health advantages. Thus, it is expected that the demand for products induced by gamma linolenic acid will increase as the number of cases of arthritis rises. Gamma linolenic acid cannot be synthesized by the human body so we must obtain it from outside sources in order to meet our body’s needs.
When gamma linolenic acid is insufficient the body undergoes certain metabolic changes. Therefore, one of the factors behind the growth of the global gamma linolenic acid market is expected to be the dependence on external sources to meet the gamma linolenic acid requirement.
Tier 1 companies includes industry leaders acquiring a 20% share in the global business market. These leaders are distinguished by their extensive product portfolio and high production capacity. These industry leaders stand out due to their broad geographic reach, in-depth knowledge of manufacturing and reconditioning across various formats and strong customer base. They offer a variety of services and manufacturing with the newest technology while adhering to legal requirements for the best quality.
Tier 2 companies include mid-size players having a presence in specific regions and highly influencing the local commerce and has a market share of 30%. These are distinguished by their robust global presence and solid business acumen. These industry participants may not have cutting-edge technology or a broad global reach but they do have good technology and guarantee regulatory compliance.
Tier 3 companies includes mostly of small-scale businesses serving niche economies and operating at the local presence having a market share of 50%. Due to their notable focus on meeting local needs these businesses are categorized as belonging to the tier 3 share segment, they are minor players with a constrained geographic scope. As an unorganized ecosystem Tier 3 in this context refers to a sector that in contrast to its organized competitors, lacks extensive structure and formalization.
The following table shows the forecasted growth rates of the significant three geographies revenues. USA, Germany and India come under the exhibit of high consumption, recording CAGRs of 6.6%, 6.7% and 6%, respectively, through 2035.
| Countries | CAGR, 2025 to 2035 |
|---|---|
| United States | 6.6% |
| Germany | 6.7% |
| India | 6% |
The United States accounts for a significant portion of the global GLA market roughly 35% of the entire market in 2024. The primary cause of this dominance is the high degree of consumer knowledge about the widespread health benefits of GLA dietary supplements and functional foods enhanced with GLA. The well-being of the area both the growing incidence of chronic illnesses and the well-established healthcare infrastructure increased GLAs demand in the pharmaceutical industry.
As an example, government surveys have shown an increasing trend in the consumption of dietary supplements containing among the omega-6 fatty acids are GLA. Nutrition research conducted high authority surveys. According to institutes consumers are becoming more interested in natural anti-inflammatory products. merchandise which increases the demand for supplements containing GLA.
Asia Pacific is growing quickly thanks to the growing nutraceutical industry. Due to its sizable population and rising disposable incomes India makes a substantial contribution. One of the main factors propelling these markets is the move toward wellness supplements and preventative healthcare.
With about 30% of the global GLA market Germany comes in second to the USA. Growing consumer preference for GLA is the main factor driving demand for the product in Europe. ingredients that are natural and plant-based especially in personal care and cosmetics. industries strict regulations and a focus on products in the nation.
The GLA market has expanded thanks in part to quality. For example, the government, according to surveys conducted in Germany the use of plant-based oils has increased skincare items. Associations for the cosmetics industry have conducted high authority surveys underlined the growing acceptance of GLA-rich oils in anti-aging products such as evening primrose and borage formulations for skin nourishment and aging.
It is said that market producers in a variety of industries strive to develop goods that help provide an effective arthritis treatment. The producers of gamma linolenic acid have the chance to improve their marketing and promotion plans. This will raise awareness of gamma linolenic acids health benefits and boost its use in a number of end-use industries.
| Report Attributes | Details |
|---|---|
| Estimated Global Industry Size (2025E) | USD 197.2 million |
| Projected Global Industry Value (2035F) | USD 269.8 million |
| Value-based CAGR (2025 to 2035) | 4.9% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | USD million for value |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, Middle East & Africa |
| Countries Covered | United States, Canada, Mexico, Brazil, Argentina, Germany, France, United Kingdom, Italy, Spain, Netherlands, China, India, Japan, South Korea, GCC Countries, South Africa |
| Key Players influencing the Market | Not specified in the provided data (can be added based on further research) |
| Additional Attributes | Dollar sales by region (North America, Europe, etc.), Trends in demand for gamma linolenic acid in pharmaceuticals, cosmetics, and nutraceuticals, Growth in sourcing from plant-based and synthetic sources, Regional dynamics across key markets in North America, Europe, and Asia-Pacific |
By nature, industry has been categorized into conventional & organic
By form industry has been categorized into liquid & powder
By end-use industry has been categorized into Dietary Functional and Supplements Foods, Food and Beverage, Pharmaceutical Industry, Animal Nutrition & Cosmetic and Personal Care
Industry analysis has been carried out in key countries of North America; Europe, Middle East, Africa, ASEAN, South Asia, Asia, New Zealand and Australia
The market is expected to grow at a CAGR of 4.9% throughout the forecast period.
By 2035, the sales value is expected to be worth USD 269.8 Million.
Growing awareness of arthritis is increasing demand for Gamma Linolenic Acid.
North America is expected to dominate the global consumption.
Some of the key players in manufacturing include Merck KGaA, Enzo Life Sciences Inc., Cayman Chemical, Thermo Fisher Scientific & Changsha Vigorous-Tech.
Explore Similar Insights
Gamma Linolenic Acid Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
